News/Press Releases

08/31/16 PluroGen to attend WUWHS Congress in Florence, IT Sept 23-25 2016

07/20/16 PluroGen Therapeutics, LLC, Announces Issuance of US Patent to Fight Biofilm in Wounds

11/01/14 New U.S. Patent Issued for PluroGel Biomaterial

09/25/14 226 Patient Paper Published Reporting Superior Results for PluroGel PSSD

09/10/14 Canada Allows Claims for Polysaccharide Natural Gel Technology Patent Application

09/02/14 Achieving Positive Results Allows Early Closure of PluroGen’s Phase II Clinical Trial

08/21/14 PluroGel PSSD Patient Paper Accepted for Publication

07/30/14 USPTO Allows Claims for Nano-silver Antimicrobial Technology Patent Application

07/21/14 USPTO Allows Claims for PluroGel Biomaterial Patent Application

07/01/14 Australia Patent Issues for PluroGel Biomaterial

06/04/14 Australia Patent Issues for Polysaccharide Natural Gel Technology

05/13/14 PluroGen to Attend European Wound Management Association (EWMA) Conference 2014, 14 to 16 May in Madrid, Spain

01/15/14 New Patent Issued for Polysaccharide Natural Gel Technology

11/11/13 PluroGen to Attend MEDICA Conference 2013, 20 to 23  November in Messe Düsseldorf, Germany

10/31/13 PluroGen Receives Marketing Approval in France

10/09/13 PluroGen Enters $126M South African Market

10/04/13 PluroGen Files New Patent Application for PluroGel Products

08/21/13 USA Phase II Clinical Trial Begins for PluroGen’s PluroGel® PN

08/15/13 PluroGen Patent Application Receives Allowance of Claims Notice

07/02/13 Ground-breaking PluroGel® Clinical Results Symposium Conducted During European Wound Management Association (EWMA) Conference 2013 15 to 17 May, Copenhagen, Denmark

04/22/13 PluroGen Therapeutics, Inc. To Attend the European Wound Management Association (EWMA) Conference 2013, 15 to 17 May in Copenhagen, Denmark

04/14/12 PluroGen Therapeutics, Inc. to Attend European Wound Management Association (EWMA) Conference 23-25 May in Vienna, AU

02/20/11 Life Science Industry Executive Elected to PluroGen Board of Directors

02/18/11 PluroGen Receives & Ships 1st Austrian Order for PluroGel® with Silver Sulphadiazine

01/20/11 PluroGen Expands into its Own 21,000 sq. ft. Multi-Purpose Facility

09/13/10 PluroGen Marks Milestone: Enters Europe with Flagship PluroGel® with Silver Sulphadiazine Makes 1st Shipment to Switzerland

09/01/10 PLUROGEN SIGNS $ 8.6 MILLION CONTRACT WITH U.S. DEPARTMENT OF DEFENSE – PLUROGEN’S PLUROGEL® PNN CHOSEN FOR LIMB SALVAGE & REGENERATIVE MEDICINE INITIATIVE

07/30/10 PHARMACEUTICAL INDUSTRY MARKETING EXECUTIVE & VAAN PROFESSIONAL ANGEL GROUP MEMBER ELECTED TO PLUROGEN BOARD OF DIRECTORS

02/11/10 VAAN MAKES SECOND INVESTMENT IN PLUROGEN